HEADER TRANSFERASE 03-DEC-04 1Y5W TITLE TRNA-GUANINE TRANSGLYCOSYLASE (TGT) IN COMPLEX WITH 6-AMINO-4-[2-(4- TITLE 2 METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: QUEUINE TRNA-RIBOSYLTRANSFERASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: TRNA-GUANINE TRANSGLYCOSYLASE, GUANINE INSERTION ENZYME; COMPND 5 EC: 2.4.2.29; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ZYMOMONAS MOBILIS; SOURCE 3 ORGANISM_TAXID: 542; SOURCE 4 GENE: TGT; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET9D KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR B.STENGL,E.A.MEYER,A.HEINE,R.BRENK,F.DIEDERICH,G.KLEBE REVDAT 6 25-OCT-23 1Y5W 1 REMARK REVDAT 5 19-AUG-20 1Y5W 1 REMARK LINK REVDAT 4 13-JUL-11 1Y5W 1 VERSN REVDAT 3 05-MAY-09 1Y5W 1 JRNL REVDAT 2 24-FEB-09 1Y5W 1 VERSN REVDAT 1 13-DEC-05 1Y5W 0 JRNL AUTH B.STENGL,E.A.MEYER,A.HEINE,R.BRENK,F.DIEDERICH,G.KLEBE JRNL TITL CRYSTAL STRUCTURES OF TRNA-GUANINE TRANSGLYCOSYLASE (TGT) IN JRNL TITL 2 COMPLEX WITH NOVEL AND POTENT INHIBITORS UNRAVEL PRONOUNCED JRNL TITL 3 INDUCED-FIT ADAPTATIONS AND SUGGEST DIMER FORMATION UPON JRNL TITL 4 SUBSTRATE BINDING JRNL REF J.MOL.BIOL. V. 370 492 2007 JRNL REFN ISSN 0022-2836 JRNL PMID 17524419 JRNL DOI 10.1016/J.JMB.2007.04.008 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH E.A.MEYER,N.DONATI,M.GUILLOT,B.SCHWEIZER,F.DIEDERICH, REMARK 1 AUTH 2 B.STENGL,A.HEINE,R.BRENK,G.KLEBE REMARK 1 TITL SYNTHESIS, BIOLOGICAL EVALUATION AND CRYSTALLOGRAPHIC REMARK 1 TITL 2 STUDIES OF EXTENDED GUANINE-BASED (LIN-BENZOGUANINE) REMARK 1 TITL 3 INHIBITORS FOR TRNA-GUANINE TRANSGLYCOSYLASE (TGT) REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 2 REMARK 2 RESOLUTION. 1.58 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.58 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.159 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.157 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.196 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 2681 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 52915 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.154 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.153 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.190 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 2389 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 47567 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2767 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 37 REMARK 3 SOLVENT ATOMS : 333 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 3136.5 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 2714.0 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 12 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 12830 REMARK 3 NUMBER OF RESTRAINTS : 11913 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 ANGLE DISTANCES (A) : 0.030 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.026 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.062 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.060 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.023 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.062 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ANISOTROPIC SCALING APPLIED BY THE REMARK 3 METHOD OF PARKIN, MOEZZI & HOPE, J.APPL.CRYST.28(1995)53-56 REMARK 4 REMARK 4 1Y5W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 08-DEC-04. REMARK 100 THE DEPOSITION ID IS D_1000031155. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-MAR-03 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC MIRRORS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR (MSC/RIGAKU) REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53930 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.580 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.4 REMARK 200 DATA REDUNDANCY : 2.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.04200 REMARK 200 FOR THE DATA SET : 21.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.58 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.61 REMARK 200 COMPLETENESS FOR SHELL (%) : 69.3 REMARK 200 DATA REDUNDANCY IN SHELL : 1.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.22100 REMARK 200 FOR SHELL : 3.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: SHELX REMARK 200 STARTING MODEL: 1P0D REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG8000, MES, DMSO, DTT, PH 5.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 45.46000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.62500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 45.46000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 32.62500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5700 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24740 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1239 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 2 REMARK 465 GLU A 3 REMARK 465 ALA A 4 REMARK 465 THR A 5 REMARK 465 ALA A 6 REMARK 465 GLN A 7 REMARK 465 GLU A 8 REMARK 465 THR A 9 REMARK 465 ASP A 10 REMARK 465 MET A 109 REMARK 465 SER A 110 REMARK 465 LEU A 111 REMARK 465 SER A 112 REMARK 465 SER A 113 REMARK 465 LEU A 114 REMARK 465 LYS A 125 REMARK 465 SER A 126 REMARK 465 HIS A 127 REMARK 465 LEU A 128 REMARK 465 ASP A 129 REMARK 465 GLY A 130 REMARK 465 SER A 131 REMARK 465 ARG A 132 REMARK 465 HIS A 133 REMARK 465 ALA A 383 REMARK 465 ARG A 384 REMARK 465 ASN A 385 REMARK 465 SER A 386 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 107 CG CD OE1 NE2 REMARK 470 VAL A 108 CG1 CG2 REMARK 470 LYS A 116 CG CD CE NZ REMARK 470 GLN A 117 CG CD OE1 NE2 REMARK 470 MET A 134 CG SD CE REMARK 470 GLN A 324 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 21 CD - NE - CZ ANGL. DEV. = 8.7 DEGREES REMARK 500 ARG A 21 NE - CZ - NH2 ANGL. DEV. = -4.6 DEGREES REMARK 500 ASN A 70 CB - CA - C ANGL. DEV. = -18.8 DEGREES REMARK 500 ASN A 70 CA - CB - CG ANGL. DEV. = -20.7 DEGREES REMARK 500 ASN A 70 OD1 - CG - ND2 ANGL. DEV. = 14.2 DEGREES REMARK 500 ASN A 70 CB - CG - ND2 ANGL. DEV. = -18.4 DEGREES REMARK 500 ARG A 77 CD - NE - CZ ANGL. DEV. = 20.2 DEGREES REMARK 500 ARG A 77 NE - CZ - NH1 ANGL. DEV. = 4.7 DEGREES REMARK 500 ARG A 82 NE - CZ - NH2 ANGL. DEV. = -4.6 DEGREES REMARK 500 ASP A 96 CB - CG - OD1 ANGL. DEV. = 6.3 DEGREES REMARK 500 ARG A 139 NE - CZ - NH1 ANGL. DEV. = 6.4 DEGREES REMARK 500 ARG A 139 NE - CZ - NH2 ANGL. DEV. = -3.7 DEGREES REMARK 500 ARG A 174 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 ARG A 177 NE - CZ - NH1 ANGL. DEV. = 5.8 DEGREES REMARK 500 ASP A 216 CB - CG - OD2 ANGL. DEV. = -5.9 DEGREES REMARK 500 TYR A 258 CB - CG - CD2 ANGL. DEV. = -4.6 DEGREES REMARK 500 TYR A 258 CB - CG - CD1 ANGL. DEV. = 5.0 DEGREES REMARK 500 ARG A 274 NE - CZ - NH1 ANGL. DEV. = 4.5 DEGREES REMARK 500 PHE A 279 CB - CG - CD1 ANGL. DEV. = -4.3 DEGREES REMARK 500 ARG A 303 NE - CZ - NH2 ANGL. DEV. = -5.5 DEGREES REMARK 500 ASP A 310 CB - CG - OD1 ANGL. DEV. = 5.5 DEGREES REMARK 500 ARG A 336 NE - CZ - NH2 ANGL. DEV. = -4.7 DEGREES REMARK 500 ARG A 378 NE - CZ - NH1 ANGL. DEV. = 4.9 DEGREES REMARK 500 ARG A 378 NE - CZ - NH2 ANGL. DEV. = -4.0 DEGREES REMARK 500 TYR A 381 CB - CG - CD2 ANGL. DEV. = 4.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 106 -55.42 -132.66 REMARK 500 LYS A 116 111.41 177.24 REMARK 500 PRO A 160 151.91 -49.26 REMARK 500 SER A 205 -131.54 50.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1273 DISTANCE = 7.31 ANGSTROMS REMARK 525 HOH A1329 DISTANCE = 6.16 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 400 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 318 SG REMARK 620 2 CYS A 320 SG 106.5 REMARK 620 3 CYS A 323 SG 115.1 117.3 REMARK 620 4 HIS A 349 ND1 104.0 113.6 99.6 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NEZ A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 610 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 620 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1Q4W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TGT IN COMPLEX WITH 2,6-DIAMINO-3H- QUINAZOLIN- REMARK 900 4-ONE REMARK 900 RELATED ID: 1R5Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TGT IN COMPLEX WITH 2,6-DIAMINO-3H- QUINAZOLIN- REMARK 900 4-ONE CRYSTALLIZED AT PH 5.5 REMARK 900 RELATED ID: 1S38 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TGT IN COMPLEX WITH 2-AMINO-8- REMARK 900 METHYLQUINAZOLIN-4(3H)-ONE REMARK 900 RELATED ID: 1Q63 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TGT IN COMPLEX WITH 2,6-DIAMINO-8-(1H- REMARK 900 IMIDAZOL-2-YLSULFANYLMETHYL)-3H-QUINAZOLINE-4-ONE CRYSTALLIZED AT REMARK 900 PH 5.5 REMARK 900 RELATED ID: 1Q65 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TGT IN COMPLEX WITH 2,6-DIAMINO-8-(2- REMARK 900 DIMETHYLAMINOETHYLSULFANYLMETHYL)-3H-QUINAZOLIN-4-ONE CRYSTALLIZED REMARK 900 AT PH 5.5 REMARK 900 RELATED ID: 1Q66 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TGT IN COMPLEX WITH 2-AMINO-6- AMINOMETHYL-8- REMARK 900 PHENYLSULFANYLMETHYL-3H-QUINAZOLIN-4-ONE CRYSTALLIZED AT PH 5.5 REMARK 900 RELATED ID: 1Y5V RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITH NE8 REMARK 900 RELATED ID: 1Y5X RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITH E89 DBREF 1Y5W A 2 386 UNP P28720 TGT_ZYMMO 1 385 SEQRES 1 A 385 VAL GLU ALA THR ALA GLN GLU THR ASP ARG PRO ARG PHE SEQRES 2 A 385 SER PHE SER ILE ALA ALA ARG GLU GLY LYS ALA ARG THR SEQRES 3 A 385 GLY THR ILE GLU MET LYS ARG GLY VAL ILE ARG THR PRO SEQRES 4 A 385 ALA PHE MET PRO VAL GLY THR ALA ALA THR VAL LYS ALA SEQRES 5 A 385 LEU LYS PRO GLU THR VAL ARG ALA THR GLY ALA ASP ILE SEQRES 6 A 385 ILE LEU GLY ASN THR TYR HIS LEU MET LEU ARG PRO GLY SEQRES 7 A 385 ALA GLU ARG ILE ALA LYS LEU GLY GLY LEU HIS SER PHE SEQRES 8 A 385 MET GLY TRP ASP ARG PRO ILE LEU THR ASP SER GLY GLY SEQRES 9 A 385 TYR GLN VAL MET SER LEU SER SER LEU THR LYS GLN SER SEQRES 10 A 385 GLU GLU GLY VAL THR PHE LYS SER HIS LEU ASP GLY SER SEQRES 11 A 385 ARG HIS MET LEU SER PRO GLU ARG SER ILE GLU ILE GLN SEQRES 12 A 385 HIS LEU LEU GLY SER ASP ILE VAL MET ALA PHE ASP GLU SEQRES 13 A 385 CYS THR PRO TYR PRO ALA THR PRO SER ARG ALA ALA SER SEQRES 14 A 385 SER MET GLU ARG SER MET ARG TRP ALA LYS ARG SER ARG SEQRES 15 A 385 ASP ALA PHE ASP SER ARG LYS GLU GLN ALA GLU ASN ALA SEQRES 16 A 385 ALA LEU PHE GLY ILE GLN GLN GLY SER VAL PHE GLU ASN SEQRES 17 A 385 LEU ARG GLN GLN SER ALA ASP ALA LEU ALA GLU ILE GLY SEQRES 18 A 385 PHE ASP GLY TYR ALA VAL GLY GLY LEU ALA VAL GLY GLU SEQRES 19 A 385 GLY GLN ASP GLU MET PHE ARG VAL LEU ASP PHE SER VAL SEQRES 20 A 385 PRO MET LEU PRO ASP ASP LYS PRO HIS TYR LEU MET GLY SEQRES 21 A 385 VAL GLY LYS PRO ASP ASP ILE VAL GLY ALA VAL GLU ARG SEQRES 22 A 385 GLY ILE ASP MET PHE ASP CYS VAL LEU PRO THR ARG SER SEQRES 23 A 385 GLY ARG ASN GLY GLN ALA PHE THR TRP ASP GLY PRO ILE SEQRES 24 A 385 ASN ILE ARG ASN ALA ARG PHE SER GLU ASP LEU LYS PRO SEQRES 25 A 385 LEU ASP SER GLU CYS HIS CYS ALA VAL CYS GLN LYS TRP SEQRES 26 A 385 SER ARG ALA TYR ILE HIS HIS LEU ILE ARG ALA GLY GLU SEQRES 27 A 385 ILE LEU GLY ALA MET LEU MET THR GLU HIS ASN ILE ALA SEQRES 28 A 385 PHE TYR GLN GLN LEU MET GLN LYS ILE ARG ASP SER ILE SEQRES 29 A 385 SER GLU GLY ARG PHE SER GLN PHE ALA GLN ASP PHE ARG SEQRES 30 A 385 ALA ARG TYR PHE ALA ARG ASN SER HET ZN A 400 1 HET NEZ A 500 24 HET GOL A 610 6 HET GOL A 620 6 HETNAM ZN ZINC ION HETNAM NEZ 6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H- HETNAM 2 NEZ IMIDAZO[4,5-G]QUINAZOLIN-8-ONE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 ZN ZN 2+ FORMUL 3 NEZ C18 H17 N5 O FORMUL 4 GOL 2(C3 H8 O3) FORMUL 6 HOH *333(H2 O) HELIX 1 1 LYS A 55 THR A 62 1 8 HELIX 2 2 THR A 71 ARG A 77 1 7 HELIX 3 3 GLY A 79 LEU A 86 1 8 HELIX 4 4 GLY A 88 GLY A 94 1 7 HELIX 5 5 SER A 136 GLY A 148 1 13 HELIX 6 6 THR A 164 ARG A 189 1 26 HELIX 7 7 ARG A 189 ALA A 196 1 8 HELIX 8 8 PHE A 207 GLY A 222 1 16 HELIX 9 9 GLY A 236 VAL A 248 1 13 HELIX 10 10 PRO A 249 LEU A 251 5 3 HELIX 11 11 LYS A 264 ARG A 274 1 11 HELIX 12 12 VAL A 282 ASN A 290 1 9 HELIX 13 13 ASN A 304 SER A 308 5 5 HELIX 14 14 CYS A 320 TRP A 326 1 7 HELIX 15 15 SER A 327 ALA A 337 1 11 HELIX 16 16 GLU A 339 GLU A 367 1 29 HELIX 17 17 ARG A 369 PHE A 382 1 14 SHEET 1 A 3 SER A 15 GLU A 22 0 SHEET 2 A 3 ALA A 25 MET A 32 -1 O GLU A 31 N SER A 15 SHEET 3 A 3 GLY A 35 THR A 39 -1 O THR A 39 N GLY A 28 SHEET 1 B 8 ALA A 41 MET A 43 0 SHEET 2 B 8 MET A 278 ASP A 280 1 O PHE A 279 N MET A 43 SHEET 3 B 8 HIS A 257 LEU A 259 1 N LEU A 259 O MET A 278 SHEET 4 B 8 GLY A 225 VAL A 228 1 N VAL A 228 O TYR A 258 SHEET 5 B 8 ALA A 197 GLN A 202 1 N GLY A 200 O ALA A 227 SHEET 6 B 8 ILE A 151 MET A 153 1 N VAL A 152 O ALA A 197 SHEET 7 B 8 ILE A 99 ASP A 102 1 N THR A 101 O ILE A 151 SHEET 8 B 8 ILE A 67 ASN A 70 1 N GLY A 69 O ASP A 102 SHEET 1 C 2 GLN A 117 SER A 118 0 SHEET 2 C 2 GLY A 121 VAL A 122 -1 O GLY A 121 N SER A 118 SHEET 1 D 2 GLN A 292 ALA A 293 0 SHEET 2 D 2 ILE A 300 ASN A 301 -1 O ILE A 300 N ALA A 293 LINK SG CYS A 318 ZN ZN A 400 1555 1555 2.31 LINK SG CYS A 320 ZN ZN A 400 1555 1555 2.31 LINK SG CYS A 323 ZN ZN A 400 1555 1555 2.29 LINK ND1 HIS A 349 ZN ZN A 400 1555 1555 2.17 CISPEP 1 THR A 39 PRO A 40 0 -4.65 CISPEP 2 ARG A 77 PRO A 78 0 8.60 CISPEP 3 TYR A 161 PRO A 162 0 3.57 CISPEP 4 VAL A 262 GLY A 263 0 -2.99 SITE 1 AC1 4 CYS A 318 CYS A 320 CYS A 323 HIS A 349 SITE 1 AC2 15 VAL A 45 LEU A 68 ASN A 70 ASP A 102 SITE 2 AC2 15 TYR A 106 ASP A 156 CYS A 158 ILE A 201 SITE 3 AC2 15 GLN A 203 GLY A 229 GLY A 230 LEU A 231 SITE 4 AC2 15 ALA A 232 MET A 260 GLY A 261 SITE 1 AC3 8 PRO A 56 GLU A 57 GLY A 94 TRP A 95 SITE 2 AC3 8 ASP A 96 ARG A 97 HOH A1269 HOH A1309 SITE 1 AC4 7 GLU A 317 LYS A 360 PHE A 373 ARG A 380 SITE 2 AC4 7 HOH A1052 HOH A1053 HOH A1270 CRYST1 90.920 65.250 69.970 90.00 95.98 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010999 0.000000 0.001152 0.00000 SCALE2 0.000000 0.015326 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014370 0.00000